Clinical characteristics of a COVID-19 cohort treated at UCLA Ronald Reagan Medical Center during the breaking phase of the pandemic: A retrospective study
Age, Anti-virals, Antibiotics, Body mass index, BMI, COVID‐19, California, Census, Coagulation, Demography, Ethnicities, Gender, Immunosuppressants, Inflammation, Intensive care/intensive care unit, Los Angeles, Obesity, Pandemic, Public health, Ronald Reagan Medical Center, SARS-COV-2, Smoking, Steroids, University of California Los Angeles, UCLA,
Related Posts
Huang X, Huffman MD, Kandula NR, Petito LC, Agarwal A, Yancy CW, Fonarow GC, Jhund PS, Mefford MT, Reynolds KL, Khan SS, Shah NS. Heart[...]
Mullen MT, Zhao J, Jiang T, Gao Z, Buechner J, Wahab F, Seo MH, Harder B, Schwamm LH, Fonarow GC, Smith EE, Xian Y, Messé[...]
Zhao X, Zhou J, Chyu KY, Erbay E, Cercek B, Shah PK, Dimayuga PC. Myeloid Fmr1 deficiency in mice results in reduced serum cholesterol and[...]